Syringe exchange in Germany.
Syringe exchange in Germany is clearly linked to a recent shift of local responses to drug-use(r) associated problem. Since the end of the 1980s, metropolitan communities in Northern and Central Germany-concerned by the emergence of "Open Drug Scenes," increasing HIV and mortality rates among drug users, and drug-use-related property crime-began to favor measures of survival-oriented drug-user help. While the Federal Government still favors repression and law enforcement efforts, they nevertheless made syringe exchange explicitly legal in 1992-some 5 years after the creation of local Syringe Exchange Programs. In general, the new approach of local authorities includes a variety of services, such as housing facilities, crisis intervention centers, primary medical care, maintenance with substitute drugs, and syringe exchange programs. The creation of pilot heroin maintenance programs is planned for Frankfurt and Hamburg. While the established programs are successfully functioning in large cities such as Hamburg, Bremen, and Frankfurt, the demand for sterile needles and syringes remains unmet in smaller cities and in the conservative governed Bundeslander (states), where pharmacies remain the primary and often single legal supply source for syringes. Another major problem continues to be the drug-use situation in prisons. Although injection drug use is common in prisons, injection equipment is not legally available for the 10,000 injecting drug users imprisoned at any given time. Two of Germany's 220 prisons started an experimental syringe exchange in 1996.
Weber
U
U
Drogenreferat der Stadt Frankfurt am Main, Frankfurt, Germany.
Schneider
W
W
D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D005858:Germany; D015658:HIV Infections / Q000209:etiology* / Q000517:prevention & control*; D006301:Health Services Needs and Demand; D006801:Humans; D018671:Needle-Exchange Programs / Q000458:organization & administration*; D010865:Pilot Projects; D011330:Prisons; D016730:Program Development; D015819:Substance Abuse, Intravenous / Q000150:complications*; D019037:Urban Health Services